Kirk Bertelsen

704 total citations
11 papers, 456 citations indexed

About

Kirk Bertelsen is a scholar working on Epidemiology, Pharmacology and Pharmacology. According to data from OpenAlex, Kirk Bertelsen has authored 11 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 3 papers in Pharmacology and 2 papers in Pharmacology. Recurrent topics in Kirk Bertelsen's work include Pharmacogenetics and Drug Metabolism (3 papers), Analytical Chemistry and Chromatography (2 papers) and Hepatitis C virus research (2 papers). Kirk Bertelsen is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Analytical Chemistry and Chromatography (2 papers) and Hepatitis C virus research (2 papers). Kirk Bertelsen collaborates with scholars based in United States, Belgium and Australia. Kirk Bertelsen's co-authors include David J. Greenblatt, Lisa L. von Moltke, R. Scott Obach, Karthik Venkatakrishnan, Gary R. Lichtenstein, Christopher D. O’Brien, Julián Panés, Richard Strauß, Hongyan Zhang and Philippe Szapary and has published in prestigious journals such as Blood, Gastroenterology and Biological Psychiatry.

In The Last Decade

Kirk Bertelsen

11 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirk Bertelsen United States	8	188	126	73	72	58	11	456
Daniel Y. Hung Australia	13	113 0.6×	138 1.1×	81 1.1×	30 0.4×	48 0.8×	20	395
Evan T. Ogburn United States	11	197 1.0×	116 0.9×	62 0.8×	65 0.9×	126 2.2×	11	567
Nancy Hakooz Jordan	15	318 1.7×	200 1.6×	43 0.6×	72 1.0×	63 1.1×	44	595
Sarah Shugarts United States	9	134 0.7×	259 2.1×	47 0.6×	40 0.6×	63 1.1×	13	691
Liliane Kiffel France	8	326 1.7×	137 1.1×	59 0.8×	24 0.3×	76 1.3×	10	478
H Kinoshita Japan	16	219 1.2×	254 2.0×	61 0.8×	32 0.4×	84 1.4×	51	591
Eman El‐Khateeb Egypt	11	133 0.7×	134 1.1×	102 1.4×	15 0.2×	31 0.5×	25	378
Justin D. Lutz United States	16	294 1.6×	219 1.7×	63 0.9×	82 1.1×	79 1.4×	21	838
Nita Patel United States	13	172 0.9×	307 2.4×	43 0.6×	30 0.4×	51 0.9×	23	644
Rahul Shah United States	14	309 1.6×	169 1.3×	48 0.7×	17 0.2×	78 1.3×	36	785

Countries citing papers authored by Kirk Bertelsen

Since Specialization

Citations

This map shows the geographic impact of Kirk Bertelsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Bertelsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Bertelsen more than expected).

Fields of papers citing papers by Kirk Bertelsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk Bertelsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Bertelsen. The network helps show where Kirk Bertelsen may publish in the future.

Co-authorship network of co-authors of Kirk Bertelsen

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk Bertelsen. A scholar is included among the top collaborators of Kirk Bertelsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk Bertelsen. Kirk Bertelsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Uchida, Naoya, Allen E. Krouse, Nathaniel S. Linde, et al.. (2021). CD117 Antibody Drug Conjugate-Based Conditioning Allows for Efficient Engraftment of Gene-Modified CD34+ Cells in a Rhesus Gene Therapy Model. Blood. 138(Supplement 1). 560–560. 4 indexed citations

Camilleri, Michael, et al.. (2020). Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data. Alimentary Pharmacology & Therapeutics. 51(11). 1139–1148. 25 indexed citations

Banerjee, Pradeep, John E. Donello, Yongxin Li, et al.. (2019). S133. AGN-241751, an Orally Bioavailable Positive NMDA Receptor Modulator, Exhibits Rapid and Sustained Antidepressant-Like Effects in Rodents. Biological Psychiatry. 85(10). S348–S348. 4 indexed citations

Sands, Bruce E., William J. Sandborn, Brian G. Feagan, et al.. (2018). Peficitinib, an Oral Janus Kinase Inhibitor, in Moderate-to-severe Ulcerative Colitis: Results From a Randomised, Phase 2 Study. Journal of Crohn s and Colitis. 12(10). 1158–1169. 99 indexed citations

Kakuda, Thomas N., Lorant Leopold, Steven Nijs, et al.. (2014). Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two-way crossover trial. The Journal of Clinical Pharmacology. 54(5). 563–573. 10 indexed citations

Buti, Marı́a, Kosh Agarwal, Yves Horsmans, et al.. (2013). Telaprevir Twice Daily Is Noninferior to Telaprevir Every 8 Hours for Patients With Chronic Hepatitis C. Gastroenterology. 146(3). 744–753.e3. 38 indexed citations

Lin, Weisheng, Xiaohua Xue, Kirk Bertelsen, et al.. (2013). A highly sensitive and selective method for the determination of leukotriene B4 (LTB4) in ex vivo stimulated human plasma by ultra fast liquid chromatography–tandem mass spectrometry. Journal of Chromatography B. 925. 54–62. 7 indexed citations

Zhang, Wei, Futian Han, Ping Guo, et al.. (2010). Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC–MS/MS—A high throughput approach to evaluate drug–drug interactions. Journal of Chromatography B. 878(15-16). 1169–1177. 35 indexed citations

Wexler, David & Kirk Bertelsen. (2010). A Brief Survey of First‐in‐Human Studies. The Journal of Clinical Pharmacology. 51(7). 988–993. 6 indexed citations

10.

Bertelsen, Kirk, David J. Greenblatt, & Lisa L. von Moltke. (2006). Apparent active transport of MDMA is not mediated by P‐glycoprotein: a comparison with MDCK and Caco‐2 monolayers. Biopharmaceutics & Drug Disposition. 27(5). 219–227. 14 indexed citations

11.

Bertelsen, Kirk, Karthik Venkatakrishnan, Lisa L. von Moltke, R. Scott Obach, & David J. Greenblatt. (2003). Apparent Mechanism-based Inhibition of Human CYP2D6 in Vitro by Paroxetine: Comparison with Fluoxetine and Quinidine. Drug Metabolism and Disposition. 31(3). 289–293. 214 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact